Lmst

Helix BioPharma reduces losses, refocuses on NSCLC therapy L-DOS47, receives positive FDA feedback, and strategically repositions for future oncology innovation. New leadership drives targeted approach to cancer treatment. #Oncology #BioPharma

ABVC BioPharma secures $1.03M in Q3 licensing revenues, highlighting strategic partnerships with OncoX BioPharma and minimal operational costs. Demonstrating strong financial performance in biotech sector. #Biopharma #Innovation

Biotechnology is shaping our world – from life-saving medicines to eco-friendly farming and AI-powered innovations. But do you know the 6 fundamentals every enthusiast must grasp to truly understand this powerful science? 🌱💊

https://drchetandhongade.com/technology/biotechnology-fundamentals/

#Biotechnology
#ScienceFacts
#GeneticEngineering
#CRISPR
#SyntheticBiology
#Nanotechnology
#AIinBiotech
#HealthcareInnovation
#FutureOfScience
#Biopharma
#GMO
#Bioinformatics
#EcoFriendlyTech
#DrChetanDhongade

🧩 The future of drug discovery may depend on how well we understand PROTAC-driven protein partnerships.

🔗 Mapping the energy landscape of PROTAC-mediated protein-protein interactions. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2023.02.049

📚 CSBJ: https://www.csbj.org/

#StructuralBiology #PROTAC #DrugDiscovery #ComputationalBiology #ProteinEngineering #ProteinDegradation #Biopharma #MedicinalChemistry #TargetedTherapies #AIinBiotech #MolecularModeling

Mapping the energy landscape of PROTAC-mediated protein-protein interactions. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2023.02.049

ABVC BioPharma receives $450,000 from OncoX BioPharma, strengthening oncology pipeline with strategic licensing agreement covering four key cancer indications. Positioning for growth in expanding $393B global cancer therapeutics market. #Oncology #Biopharma

💊 Big news in biopharma! Johnson & Johnson is investing $2B to expand in North Carolina, while Syngene is establishing its first U.S. facility in Baltimore. These projects bring jobs, innovation, and economic growth to two thriving regions. 🌟 #Biopharma #EconDev #JohnsonAndJohnson #Syngene #BusinessExpansion #EconomicGrowth

🔬 Microbial Fermentation Tech Market 2025
Expected to grow from $37.46B (2024) to $57.14B (2029) at an 8.7% CAGR.
Fueled by demand in biosimilars, fermented foods, alcoholic beverages, and synthetic biology.

📥 Free sample:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15862&type=smp
#Biotech #Fermentation #CRISPR #SyntheticBiology #FoodTech #BioPharma

NewAge Industries welcomes Mark Thornton and Rick Chomik to leadership roles, bringing extensive biopharma and operational expertise to drive strategic growth and innovation #Leadership #Biopharma

ABVC BioPharma secures $150K milestone from AiBtl, advancing CNS therapeutic solutions through innovative licensing strategy. Total licensing revenue reaches $846K, reinforcing commitment to botanical drug development. #Biopharma #Innovation

🚨 Advance your #RegulatoryAffairs career!

Master strategic planning, lifecycle & global dossier management.
🎓 For mid–senior RA professionals
🔗 https://zurl.co/jKJh3

#Pharma #Biopharma #RAstrategy #RoyedTraining #CareerGrowth #strategicmanagement

regulatory affairs strategic management course

but the stock may be oversold given current political headwinds.
Contrarian opportunity or continued headwinds? What's your take? 🎯
Get the complete analysis: https://www.theinsidersfund.com/2025/06/insider-buying-week-05-30-25-could-harvard-university-go-public/
#InsiderBuying #AVTR #Biopharma #Contrarian #NotInvestmentAdvice

Master Biopharmaceutical Project Management with Royed's exclusive certification course!
Build turnkey decision-making skills to lead biologics & biosimilar projects from R&D to launch.
📍Enroll now: https://zurl.co/OudGj
#Biopharma #ProjectManagement #RoyedTraining

Quantum BioPharma resolves legal dispute with former CEO, secures $2.35M settlement, reinforcing strategic focus on innovative biotech solutions and medical research. #Biopharma #Innovation

Quantum BioPharma receives Australian ethics approval for Phase 2 clinical trial of FSD202, targeting chronic MCAS-related pain and exploring innovative treatment strategies. Promising research for patients with complex inflammatory conditions. #MedicalResearch #Biopharma

🚀 Build your expertise in #Biopharma #BD

Royed's Online Certification Course covers BD, Licensing, Valuation, Forecasting, Market Access and Pricing —tailored for Biologics & Biosimilars.

🔗 https://zurl.co/Qi3gh
#PharmaTraining #Biosimilars #Biologics

🚀 Royed's Biopharma Global Business Course!
🌍 Designed for #Biologics & #Biosimilars pros to master regulatory, market access, CMC, digital & more.
📚 100% online | Self-paced | Certificate
🔗 https://zurl.co/Dzdcx
#BioPharma #PharmaBusiness #RoyedTraining #biopharmaBD

to customers in the biopharma, healthcare, education, government, and advanced technologies sectors, providing materials, consumables, custom solutions, &comprehensive lab services.
When two directors invest substantially within days of each other despite industry headwinds, does this signal they see light at the end of the tunnel? How might Avantor's diversified customer base help it weather current challenges?
#InsiderBuying #AVTR #Biopharma #NotInvestmentAdvice
More @ https://www.theinsidersfund.com/2025/05/insider-buying-week-05-09-25-bargain-basement-week/

Corcept Therapeutics falls short of Wall Street expectations in Q1 CY2025, generating $157.2 million despite a 7.1% year-over-year growth. This scenario signals potential market challenges that may shape future strategies. Insights from financial performance highlight resilience in the biopharmaceutical sector. For further analysis, click the link: https://finance.yahoo.com/news/corcept-nasdaq-cort-misses-q1-210445208.html #CorceptTherapeutics #Q12025 #Biopharma #RevenueGrowth #CORT

EUROSCOPE | RÉENCHANTER LA BIOMÉDECINE

Essais, biomanufacture, investissements : face aux géants, l’UE doit redevenir phare et pas simple port. Guérir plus vite, produire mieux, investir plus justement.

https://whatsapp.com/channel/0029VaE5Wl8Dp2Q7vJyg0G30

#EuroScope #Biopharma #Innovation #SouverainetéSanitaire #Compétitivité